UPDATE 2-Drugmaker Shire wins Baxalta for $32 bln after 6-month pursuit

* Baxalta haemophilia business a potential product risk (Adds further CEO comment, analyst reaction, latest shares)

from Reuters: New Issues News http://ift.tt/1Ri296P